No Data
No Data
No Data
No Data
No Data
How Is The Market Feeling About Marinus Pharma?
Marinus Pharma's (NYSE:MRNS) short percent of float has fallen 3.64% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 6.35% of all regular shar
BenzingaApr 29 22:45
Market Cool On Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Revenues Pushing Shares 84% Lower
The Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) share price has fared very poorly over the last month, falling by a substantial 84%. For any long-term shareholders, the last month ends a year to fo
Simply Wall StApr 25 19:33
Marinus Pharmaceuticals Price Target Cut to $10.00/Share From $25.00 by Truist Securities
Marinus Pharmaceuticals Price Target Cut to $10.00/Share From $25.00 by Truist Securities
Dow JonesApr 18 19:24
Truist Securities: Maintaining Marinus Pharma (MRNS.US) rating, adjusted from buy to buy rating, and adjusted target price from $25.00 to $10.00.
Truist Securities: Maintaining Marinus Pharma (MRNS.US) rating, adjusted from buy to buy rating, and adjusted target price from $25.00 to $10.00.
Zhitong FinanceApr 18 19:20
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwri
BenzingaApr 17 20:21
Marinus Pharmaceuticals Price Target Cut to $2.00/Share From $20.00 by Baird
Marinus Pharmaceuticals Price Target Cut to $2.00/Share From $20.00 by Baird
Dow JonesApr 17 17:24
No Data
No Data